Baker Bros. Advisors as of March 31, 2016
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 134 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Incyte Corporation (INCY) | 18.0 | $1.7B | 24M | 72.47 | |
| Seattle Genetics | 16.0 | $1.5B | 43M | 35.09 | |
| Alexion Pharmaceuticals | 9.6 | $911M | 6.5M | 139.22 | |
| Abbvie (ABBV) | 8.7 | $821M | 14M | 57.12 | |
| ACADIA Pharmaceuticals (ACAD) | 7.1 | $677M | 24M | 27.96 | |
| Incyte Corp Ltd conv | 4.5 | $431M | 275M | 1.57 | |
| Incyte Corp Incy Cvt 144a 0.37 convert | 4.2 | $399M | 259M | 1.54 | |
| BioMarin Pharmaceutical (BMRN) | 4.2 | $396M | 4.8M | 82.48 | |
| Genomic Health | 3.6 | $338M | 14M | 24.77 | |
| Anacor Pharmaceuticals In | 2.9 | $274M | 5.1M | 53.45 | |
| Dbv Technologies S A (DBVT) | 1.9 | $179M | 5.5M | 32.55 | |
| Acorda Therapeutics | 1.0 | $97M | 3.7M | 26.45 | |
| Biomarin Pharmaceutical Inc note 1.875% 4/2 | 0.9 | $90M | 22M | 4.01 | |
| Clovis Oncology Inc note 2.500% 9/1 | 0.9 | $88M | 129M | 0.68 | |
| Gilead Sciences conv | 0.9 | $86M | 21M | 4.10 | |
| Cerus Corporation (CERS) | 0.8 | $80M | 14M | 5.93 | |
| Anacor Pharmaceuticals Inc note 2.000%10/1 | 0.8 | $75M | 42M | 1.79 | |
| Xenoport Inc convertible security | 0.8 | $73M | 100M | 0.73 | |
| Mirati Therapeutics | 0.7 | $70M | 3.3M | 21.40 | |
| Aquinox Pharmaceuticals | 0.7 | $68M | 7.8M | 8.82 | |
| Acorda Therap note 1.75% 6/15 | 0.7 | $69M | 77M | 0.89 | |
| Invitae (NVTAQ) | 0.7 | $67M | 6.6M | 10.23 | |
| Beigene (BGNE) | 0.6 | $56M | 1.9M | 29.31 | |
| Heron Therapeutics (HRTX) | 0.6 | $55M | 2.9M | 18.99 | |
| Bellicum Pharma | 0.5 | $46M | 4.9M | 9.35 | |
| BioCryst Pharmaceuticals (BCRX) | 0.5 | $43M | 15M | 2.83 | |
| ImmunoGen | 0.4 | $38M | 4.5M | 8.52 | |
| Spark Therapeutics | 0.4 | $37M | 1.3M | 29.51 | |
| Neurocrine Biosciences (NBIX) | 0.4 | $35M | 895k | 39.55 | |
| Versartis | 0.3 | $26M | 3.2M | 8.02 | |
| Sangamo Biosciences (SGMO) | 0.3 | $25M | 4.1M | 6.05 | |
| Advanced Accelerat spon ads each rep 2 ord | 0.2 | $22M | 615k | 35.02 | |
| Exelixis Inc cnv | 0.2 | $20M | 20M | 0.99 | |
| Progenics Pharmaceuticals | 0.2 | $19M | 4.4M | 4.36 | |
| Achillion Pharmaceuticals | 0.2 | $19M | 2.5M | 7.72 | |
| Insmed (INSM) | 0.2 | $19M | 1.5M | 12.67 | |
| Halozyme Therapeutics (HALO) | 0.2 | $18M | 1.9M | 9.47 | |
| Tg Therapeutics (TGTX) | 0.2 | $17M | 2.0M | 8.52 | |
| Intra Cellular Therapies (ITCI) | 0.2 | $17M | 609k | 27.80 | |
| XenoPort | 0.2 | $16M | 3.5M | 4.51 | |
| Medivation | 0.2 | $15M | 330k | 45.98 | |
| Bluebird Bio (BLUE) | 0.2 | $15M | 353k | 42.50 | |
| Idera Pharmaceuticals | 0.1 | $14M | 7.0M | 1.98 | |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.1 | $14M | 12M | 1.16 | |
| Foamix Pharmaceuticals | 0.1 | $15M | 2.2M | 6.52 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.1 | $14M | 27M | 0.51 | |
| Array BioPharma | 0.1 | $13M | 4.3M | 2.95 | |
| Novavax | 0.1 | $12M | 2.4M | 5.16 | |
| Agios Pharmaceuticals (AGIO) | 0.1 | $13M | 308k | 40.60 | |
| Corsicanto Ltd conv bnd | 0.1 | $12M | 15M | 0.81 | |
| Galapagos Nv- (GLPG) | 0.1 | $13M | 303k | 41.82 | |
| Omeros Corporation (OMER) | 0.1 | $12M | 749k | 15.34 | |
| Derma Sciences | 0.1 | $12M | 3.8M | 3.10 | |
| Xencor (XNCR) | 0.1 | $12M | 872k | 13.42 | |
| Exelixis (EXEL) | 0.1 | $10M | 2.6M | 4.00 | |
| Ascendis Pharma A S (ASND) | 0.1 | $9.4M | 506k | 18.55 | |
| Zogenix | 0.1 | $9.2M | 1.0M | 9.24 | |
| Global Blood Therapeutics In | 0.1 | $9.5M | 600k | 15.86 | |
| Dimension Therapeutics | 0.1 | $9.8M | 1.3M | 7.83 | |
| Alkermes (ALKS) | 0.1 | $8.6M | 250k | 34.19 | |
| Alcobra | 0.1 | $8.9M | 2.3M | 3.79 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.1 | $8.4M | 2.1M | 3.94 | |
| Ligand Pharmaceuticals In (LGND) | 0.1 | $7.9M | 73k | 107.09 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $7.8M | 124k | 63.31 | |
| Sage Therapeutics (SAGE) | 0.1 | $7.2M | 224k | 32.06 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.1 | $6.4M | 5.5M | 1.17 | |
| Macrogenics (MGNX) | 0.1 | $6.8M | 364k | 18.75 | |
| Concert Pharmaceuticals I equity | 0.1 | $6.8M | 496k | 13.66 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $6.6M | 1.3M | 4.88 | |
| Endocyte | 0.1 | $5.3M | 1.7M | 3.10 | |
| Lion Biotechnologies | 0.1 | $5.4M | 1.1M | 5.08 | |
| Dermira | 0.1 | $5.7M | 275k | 20.68 | |
| Akari Therapeutics | 0.1 | $5.5M | 396k | 14.00 | |
| Neuroderm Ltd F | 0.1 | $4.3M | 305k | 14.12 | |
| Natera (NTRA) | 0.1 | $4.3M | 450k | 9.52 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.1 | $4.9M | 1.0M | 4.82 | |
| Medgenics | 0.0 | $3.4M | 765k | 4.40 | |
| Aerie Pharmaceuticals | 0.0 | $3.6M | 299k | 12.16 | |
| Trevena | 0.0 | $3.7M | 450k | 8.27 | |
| Ignyta | 0.0 | $3.9M | 571k | 6.77 | |
| Vitae Pharmaceuticals | 0.0 | $4.2M | 638k | 6.63 | |
| Loxo Oncology | 0.0 | $3.8M | 138k | 27.34 | |
| Seres Therapeutics (MCRB) | 0.0 | $3.3M | 125k | 26.56 | |
| Aimmune Therapeutics | 0.0 | $3.4M | 250k | 13.56 | |
| Osiris Therapeutics | 0.0 | $2.9M | 499k | 5.71 | |
| Curis | 0.0 | $3.2M | 2.0M | 1.61 | |
| Sunesis Pharmaceuticals | 0.0 | $2.4M | 4.5M | 0.54 | |
| Epizyme | 0.0 | $2.8M | 233k | 12.12 | |
| Uniqure Nv (QURE) | 0.0 | $2.7M | 230k | 11.88 | |
| Adamas Pharmaceuticals | 0.0 | $2.5M | 173k | 14.46 | |
| Juno Therapeutics | 0.0 | $3.0M | 80k | 38.09 | |
| Invivo Therapeutics Hldgs | 0.0 | $2.8M | 400k | 6.98 | |
| Nabriva Therapeutics | 0.0 | $3.1M | 350k | 8.96 | |
| Ironwood Pharmaceuticals (IRWD) | 0.0 | $1.9M | 169k | 10.94 | |
| Cytrx | 0.0 | $1.8M | 660k | 2.68 | |
| Enanta Pharmaceuticals (ENTA) | 0.0 | $2.2M | 75k | 29.37 | |
| D Stemline Therapeutics | 0.0 | $1.6M | 334k | 4.66 | |
| Array Biopharma Inc note 3.000% 6/0 | 0.0 | $2.4M | 3.0M | 0.79 | |
| Ophthotech | 0.0 | $1.5M | 36k | 42.27 | |
| Karyopharm Therapeutics (KPTI) | 0.0 | $1.9M | 217k | 8.92 | |
| Mediwound Ltd cmn | 0.0 | $1.8M | 226k | 8.07 | |
| Immune Design | 0.0 | $1.9M | 149k | 13.00 | |
| Aurinia Pharmaceuticals (AUPH) | 0.0 | $2.1M | 712k | 2.93 | |
| Affimed Therapeutics B V | 0.0 | $1.5M | 400k | 3.74 | |
| Dynavax Technologies (DVAX) | 0.0 | $1.4M | 75k | 19.24 | |
| Protalix Biotherapeutics Inc note 4.500% 9/1 | 0.0 | $2.3M | 3.4M | 0.68 | |
| Proteon Therapeutics | 0.0 | $2.3M | 299k | 7.74 | |
| Trillium Therapeutics, Inc. Cmn | 0.0 | $2.0M | 212k | 9.25 | |
| Ionis Pharmaceuticals (IONS) | 0.0 | $2.3M | 57k | 40.50 | |
| Alnylam Pharmaceuticals (ALNY) | 0.0 | $712k | 11k | 62.79 | |
| BioDelivery Sciences International | 0.0 | $678k | 210k | 3.23 | |
| Amarin Corporation (AMRN) | 0.0 | $1.2M | 802k | 1.53 | |
| Palatin Technologies | 0.0 | $1.1M | 2.1M | 0.54 | |
| Mast Therapeutics | 0.0 | $1.3M | 4.8M | 0.27 | |
| Gw Pharmaceuticals Plc ads | 0.0 | $1.1M | 15k | 72.13 | |
| Chimerix (CMRX) | 0.0 | $589k | 115k | 5.11 | |
| Acceleron Pharma | 0.0 | $759k | 29k | 26.39 | |
| Five Prime Therapeutics | 0.0 | $782k | 19k | 40.63 | |
| Aldeyra Therapeutics (ALDX) | 0.0 | $595k | 142k | 4.19 | |
| Assembly Biosciences | 0.0 | $1.3M | 250k | 5.02 | |
| Tenax Therapeutics | 0.0 | $861k | 420k | 2.05 | |
| Cellectis S A (CLLS) | 0.0 | $1.4M | 50k | 27.50 | |
| Adaptimmune Therapeutics (ADAP) | 0.0 | $813k | 100k | 8.13 | |
| Arbutus Biopharma (ABUS) | 0.0 | $746k | 181k | 4.13 | |
| Pronai Therapeutics | 0.0 | $1.3M | 200k | 6.74 | |
| Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $76k | 13k | 5.73 | |
| Chemocentryx | 0.0 | $122k | 49k | 2.49 | |
| Foundation Medicine | 0.0 | $380k | 21k | 18.19 | |
| La Jolla Pharmaceuticl Com Par | 0.0 | $287k | 14k | 20.88 | |
| Achaogen | 0.0 | $276k | 100k | 2.76 | |
| Biotime Inc wts oct 1 18 | 0.0 | $12k | 20k | 0.60 | |
| Aptose Biosciences | 0.0 | $100k | 33k | 2.99 | |
| Ritter Pharmaceuticals | 0.0 | $452k | 400k | 1.13 | |
| Discovery Laboratories | 0.0 | $426k | 255k | 1.67 |
